Curexbio

  Central Laboratory Support in Singapore plays an important role in maintaining sample integrity and data quality across early- and mid-phase clinical research. Singapore is an emerging hub for clinical research, benefiting from clear regulations and strong research networks. Its infrastructure supports multi-country studies, but data integrity challenges can arise after sample collection, as tracking and storage issues can quickly escalate in regional trials. This post examines common failure points in sample management for Singapore-based and Asia-Pacific studies. It describes the effective strategies employed by a well-run central laboratory support model to address these issues.  Most deviations related to samples are minor, recurring issues that build up over time across different sites and visits.  Figure 1:  Deviations related to samples across sites Table of Contents Central Laboratory Support in Singapore: Key Considerations What Effective Central Laborator...